Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	6.43B -19.7%
Revenue (ttm)	3.68B -7.4%
Net Income	168.94M -28.2%
EPS	0.16 -30.4%
Shares Out	1.02B
PE Ratio	39.54
Forward PE	26.75
Dividend	0.06 (0.90%)
Ex-Dividend Date	n/a

Volume	5,086,626
Average Volume	7,284,872
Open	6.36
Previous Close	6.33
Day's Range	6.27 - 6.40
52-Week Range	6.27 - 9.42
Beta	1.01
RSI	33.78
Earnings Date	Aug 24, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant ex...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,514
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2025, SHA:600223's revenue was 3.65 billion, a decrease of -8.33% compared to the previous year's 3.98 billion. Earnings were 187.75 million, a decrease of -22.90%.